This one fell out of parallel channel but will bounce back. Small float with high short interest, high institutional holders and 5 million market cap. Late stage in clinical trials. This has so much going for it.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
